Sonu Real-World Use Clinical Study to Treat Moderate to Severe Nasal Congestion
NCT ID: NCT06024564
Last Updated: 2025-01-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
121 participants
INTERVENTIONAL
2023-08-08
2024-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sonu Nasal Congestion Relief Study in Patients Suffering From Moderate to Severe Nasal Congestion
NCT05821842
Acoustic Resonance Therapy for Treating Empty Nose Syndrome
NCT07215013
A User Study of the Soniflow System for Nasal Congestion Relief
NCT04910139
Effects of SinuSonic on Psychological and Physical Well-Being
NCT06268730
The Safety and Efficacy of a SinuSonic Intervention
NCT03906968
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Interventional
Participants will receive Acoustic Resonance Therapy using the Sonu headband and App, twice a day, for 90 days
Sonu Acoustic Resonance Therapy
Participants will receive Sonu treatment twice a day for 90 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sonu Acoustic Resonance Therapy
Participants will receive Sonu treatment twice a day for 90 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Present with symptoms of chronic nasal congestion
* Have a 24 hour reflective nasal congestion subscore of the TNSS of 2 or more on a 0 to 3 scale at the time of screening
Exclusion Criteria
* Pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Third Wave Therapeutics
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jacob Johnson, MD
Role: PRINCIPAL_INVESTIGATOR
San Francisco Otolaryngology Medical Group
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
San Francisco Otolaryngology Medical Group
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP-007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.